🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Stem Cell Donors

Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant NCT03921047n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Laboratory Biomarker Analysis CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia NCT06633328EARLY Phase 11 site📍 Hanzhou Zhejiang University · Tests: CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® NCT02007356Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: IFN-γ positive selected T-cells Umbilical Cord Stem Cells for Skin Grafts in Donor Site Wounds NCT05984628NA1 site📍 Fujian Fujian Medical University Union Hospital · Tests: human umbilical cord mesenchymal stem cells, blank solvent Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant NCT03354728Phase 1, Phase 21 site📍 Duarte City of Hope Medical Center · Tests: Laboratory Biomarker Analysis, Multi-peptide CMV-Modified Vaccinia Ankara Vaccine Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease NCT06941389n/a37 sites📍 Birmingham📍 Birmingham📍 Wilmington University of Rochester Randomised Controlled Trial Comparing CD62L and CD45RA Depleted Donor Lymphocyte Infusion With T-cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation NCT07867769Phase 21 site📍 Hong Kong Hong Kong Children's Hospital · Tests: CD62L depleted DLI, CD45RA depleted DLI, Haploidentical HSCT Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders NCT03980769Phase 21 site📍 Seattle Fred Hutchinson Cancer Center · Tests: Thiotepa, Treosulfan, Fludarabine Phosphate, Rabbit Anti-Thymocyte Globulin, Allogeneic Hematopoietic Stem Cell Transpl… Combined Kidney and Hematopoietic Stem Cell Transplantation for Tolerance Induction NCT05086003Phase 21 site📍 Petah Tikva Rabin Medical Center · Tests: Combined kidney and bone marrow transplantation Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy NCT03000244n/a1 site📍 Bethesda National Cancer Institute (NCI) CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant NCT06059391Phase 23 sites📍 Duarte📍 Atlanta📍 Boston City of Hope Medical Center · Tests: Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Granulocyte Colony-Stimulating Factor, Hema… CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT NCT07441291Phase 31 site📍 Beijing Peking University People's Hospital · Tests: CAR-T, DLI Exercise as an Immune Adjuvant for Allogeneic Cell Therapies NCT06643221EARLY Phase 11 site📍 Tucson University of Arizona · Tests: Exercise, Isoproterenol, Placebo, Bisoprolol Fumarate Tablet 10 mg, Nadolol (1 x 80 mg) Tablets (Invamed, Inc) 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome NCT06287944Phase 11 site📍 Duarte City of Hope Medical Center · Tests: Actinium Ac 225-DOTA-Daratumumab, Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy, Computed Tomograp… Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease NCT02675959Phase 24 sites📍 Los Angeles📍 Gainesville📍 Valhalla New York Medical College · Tests: Defibrotide Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation NCT06529731Phase 23 sites📍 St Louis📍 Pittsburgh📍 Seattle Sawa Ito, MD · Tests: Interferon gamma-1b, Donor Leukocyte Infusion (DLI) Immune Reconstitution in Stem Cell Transplant Recipients NCT02129543n/a1 site📍 Miami University of Miami · Tests: Blood Draw Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) NCT01666080NA1 site📍 Minneapolis Masonic Cancer Center, University of Minnesota · Tests: Busulfan, Fludarabine, Total body irradiation, Stem cell transplant, Keppra A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant NCT07020533Phase 13 sites📍 Duarte📍 Atlanta📍 Boston City of Hope Medical Center · Tests: Biospecimen Collection, Electronic Health Record Review, Haploidentical Hematopoietic Cell Transplantation, Letermovir,… TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies NCT07052370Phase 11 site📍 Memphis St. Jude Children's Research Hospital · Tests: Thymoglobulin, Cyclophosphamide, Fludarabine, Thiotepa, Melphalan Feasibility and Safety of Donor-derived NK-cell Infusions for Leukemia Relapse Prophylaxis After Hematopoietic Stem Cell Transplantation NCT07256210Phase 21 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Donor-derived Natural Killer Cell Immune Tolerance Induction After Liver Transplantation NCT07269041Phase 1, Phase 21 site📍 Los Angeles University of California, Los Angeles · Tests: Donor Hematopoietic Stem and Progenitor Cell Infusion Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) NCT03970096Phase 23 sites📍 Tampa📍 Pittsburgh📍 Seattle Fred Hutchinson Cancer Center · Tests: Total-Body Irradiation, Thiotepa, Fludarabine, Tacrolimus, Allogeneic CD34+-enriched and CD45RA-depleted PBSCs Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies NCT07285668NA1 site📍 Madison University of Wisconsin, Madison · Tests: Allogeneic donor TCRαβ+/CD19+ cell-depleted peripheral blood mononuclear cells VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT NCT06447090Phase 21 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: Mitoxantrone hydrochloride liposome Impact of Stem Cell Donation on Unrelated and Related Donors' Health. NCT06905704n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives NCT00001529n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) · Tests: G-CSF Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure NCT03500731Phase 1, Phase 22 sites📍 Pittsburgh📍 Pittsburgh Paul Szabolcs · Tests: CD3/CD19 negative hematopoietic stem cells, Rituximab, Alemtuzumab, Fludarabine, Thiotepa CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation NCT06034535Phase 21 site📍 Hong Kong Hong Kong Children's Hospital · Tests: CD62L depleted donor lymphocyte infusion Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies NCT07366801Phase 2, Phase 31 site📍 Moscow Federal Research Institute of Pediatric Hematology, Oncolog… · Tests: Cyclosporine A (CsA), Sirolimus, Ruxolitinib (JAKAVI®), Abatacept
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy